Clinical Trial Update: Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver Injury

View source ↗

Summary

IV fish oil for parenteral nutrition–associated liver injury has been approved for marketing, marking regulatory clearance for this therapy in liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• IV fish oil (omega-3 fatty acids (intravenous))

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Liver Disease | Status: APPROVED_FOR_MARKETING